Market Extra: Why investors should ‘let the dust settle’ as Dow jumps 1,300 points on Pfizer vaccine news

No Comments
Uncategorized

Stocks soar back to record territory as Pfizer and BioNTech offer good news on their COVID-19 vaccine trial. But investors might be overlooking some things.

Stocks soar back to record territory as Pfizer and BioNTech offer good news on their COVID-19 vaccine trial. But investors might be overlooking some things.